Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IronHeart: Ferric Carboxymaltose in HFrEF
NCT03871699Phase 4Unknown
- Sponsor
- Hospital Moinhos de Vento
- Start
- Aug 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), heart failure with reduced ejection fraction (HFrEF), sponsored by Hospital Moinhos de Vento. Status: unknown.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT03871699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03871699.